IGF2BP2 and neoplasm: METTL3 also promotes tumor angiogenesis by modifying Ephrin-A receptor 2(EphA2) and vascular endothelial growth factor A (VEGFA) mRNAs with m6A, facilitating their recognition by IGF2BP2/3, stabilizing the mRNA, and enhancing protein translation.